Insulin Pump or Automated Insulin Delivery Start Visit Note

Comprehensive template for insulin pump and automated insulin delivery (AID) system start visits, covering device selection, training documentation with competency verification, initial settings, and explicit safety plan…

Document Type

clinical note / Initial Evaluation Note

Specialties

Pediatric Endocrinology
Created by Augustun

Template Preview

Date/Time: [Date and time of encounter]

Patient: [Patient name / MRN]

Visit Type: [in-person / video / phone / hybrid]

Visit Stage: [device selection / training day / activation day / early follow-up]

Participants: [Patient, caregiver(s), interpreter, device trainer, clinician(s) present]

Data Sources Reviewed: [Device downloads, CGM reports, pump history, glucose logs, labs, external records reviewed]

Reason for Visit

[Patient-centered reason for visit: pump start / AID initiation / AID upgrade / pump replacement / transition from MDI] (For upgrades or switches, include why now: coverage change, device issues, glycemic concerns, quality of life, pregnancy planning.)

History of Present Illness

[Current insulin regimen and delivery method, approximate total daily dose, CGM/BGM use, and key glycemic patterns prompting change]

[Goals for technology: reduce hypoglycemia, improve time-in-range, reduce burden, overnight control] [Brief patient quote if it clarifies goals or concerns]

[Prior pump/AID/CGM experience and reasons for any discontinuation] [Readiness factors: carb counting skills, ability to respond to alarms, caregiver involvement] [Safety-relevant history: severe hypoglycemia, hypoglycemia unawareness, DKA history, adhesive reactions, infusion site issues, supply barriers] [Shared decision-making summary: options discussed, preferences, constraints including insurance, dexterity, vision, language needs]

Relevant Background

(Omit this section if no factors materially affect device choice, safety, or settings.)

  • [Diabetes type, duration, relevant complications]
  • [Comorbidities affecting glycemia or device safety: steroids, gastroparesis, pregnancy, dialysis schedule]
  • [Allergies/sensitivities: adhesives, insulin]
  • [Social factors affecting safe use: food access, work/school schedule, travel, storage, housing stability]

Objective

  • Vitals: [Weight (required for dosing), BP, HR, height/BMI] (If telehealth, note patient-reported values or "Not obtained.")
  • Skin Exam: [Inspection of infusion/injection sites for lipohypertrophy, lipoatrophy, scarring, dermatitis; dexterity/vision observations] (If not assessed, state reason.)
  • Labs: [Most recent A1c with date] [Renal function or other labs only if impacting dosing or device safety]
  • Device Data Summary: [CGM metrics: date range, % wear, TIR/TBR/TAR, GMI, notable patterns] [Pump data: TDD, basal/bolus distribution, prior settings if upgrading]

Device Selection and Rationale

Device(s) Selected:

  • Pump/AID system: [Name and model]
  • CGM: [Model and integration type]
  • Infusion set: [Cannula type, length, tubing length] (Omit for tubeless patch pumps.)
  • Insulin type for pump: [Rapid-acting insulin name]
  • For upgrades: [What is changing from prior system]

Rationale:

  • [Clinical reasoning: hypoglycemia reduction, TIR improvement, integration needs]
  • [Patient preferences/constraints: wearability, alarm profile, vision/dexterity]
  • [Coverage/affordability and supply considerations]

Start Logistics:

  • [Planned activation date]
  • [Who will perform activation]
  • [Training modality: in-person / video / phone / hybrid]
  • [Data-sharing platform and setup status]

Education and Training

(Clearly distinguish completed from planned/deferred training. Document only what was taught and demonstrated—do not infer competency.)

Training Completed Today:

  • Trainer and methods: [Trainer name/credentials] [Methods: demonstration, teach-back, return demonstration, written materials, video modules]
  • Topics covered: [Device fundamentals: reservoir/pod fill, priming, insertion, site rotation, set changes, troubleshooting] [AID-specific: automated vs manual modes, meal boluses, temp targets/exercise mode, delivery limits] [CGM integration: pairing, calibrations, alert management] [Data upload/sharing]
  • Competency validation: [What patient/caregiver demonstrated: insertion, test bolus, acknowledging alerts, mode changes] (If demonstration not possible, document why and mitigation plan.)

Previously Completed: [Prior training topics, dates, source]

Planned/Deferred: [Topics for next session, planned date, reason for deferral]

Initial Settings

Status: [Programmed today / Planned for activation on (date)]

  • Basal profile(s): [Rates and time blocks, or note if algorithm-determined with inputs used]
  • Insulin-to-carbohydrate ratio(s): [Time blocks and ratios]
  • Insulin sensitivity factor(s): [Time blocks and factors]
  • Glucose/correction target(s): [Target values and time blocks]
  • Active insulin time: [Duration]
  • Maximum bolus limit: [Value]
  • Alert settings: [Low glucose threshold, urgent low threshold, high glucose threshold]
  • Special modes enabled: [Sleep mode, activity/exercise mode defaults]

Basis for Settings: [Prior pump settings carried forward vs changed; weight-based or MDI conversion; CGM pattern review]

Safety Planning

Backup Insulin Plan

  • [Long-acting insulin prescription and dose if pump stopped >24 hours, with timing instructions]
  • [Rapid-acting insulin via pen/syringe for corrections with dosing]
  • [Confirmation patient has supplies and understands when to use]

Ketone and Infusion Failure Plan

  • Suspect infusion failure when: [Persistent hyperglycemia despite correction, repeated alarms, unexplained rising glucose]
  • Ketone testing: [When to check with glucose/time thresholds] [Blood vs urine method]
  • Actions if ketones present: [Hydration, immediate set/pod change, correction by injection (not pump), recheck interval, when to seek emergency care: vomiting, abdominal pain, rapid breathing, altered mental status]
  • [Ketone testing supplies confirmed available]

Hypoglycemia Plan

  • [Recognition and treatment: fast-acting glucose source, amount, retest timing]
  • [Glucagon availability, location, and who is trained to administer]
  • [Special considerations: driving, exercise, alcohol, work/school]

Supplies Confirmed

[Extra infusion sets/pods, extra insulin, ketone strips/meter, batteries/charger, adhesive supplies, glucose tabs, glucagon]

Follow-up and Data Review Plan

Initial Follow-up Schedule:

  • [First check-in: timing, modality, responsible team member]
  • [Next clinic/telehealth visit]
  • [Expected frequency of setting adjustments in first month]

Data Sharing:

  • [Platform used, sharing status: active / pending]
  • [Data review windows: first 72 hours, first 14 days]
  • [Triggers for outreach: recurrent lows, sustained highs, automation off time, site failures]

Patient Communication: [How to contact clinic, expected response time, after-hours escalation]

Orders

(Include only orders placed or renewed today.)

  • [Pump/AID supplies: sets, pods, reservoirs]
  • [CGM supplies: sensors, transmitters]
  • [Insulins: pump rapid-acting, backup long-acting]
  • [Ketone testing supplies]
  • [Glucagon]
  • [Referrals: diabetes education, nutrition, behavioral health, school orders]

Assessment and Plan

[Summary assessment: diabetes context, device/therapy initiated or planned, key safety measures in place, follow-up timeline] (Include any prerequisites not yet met and the interim plan. If activation deferred, document what is missing, why it matters, interim regimen, and when activation will occur.)

Want to use this template?

Copy it into your workflow, or book a demo to see Augustun draft notes like this automatically.